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Angiotensin-converting enzyme (ACE) is a zinc metallopeptidase
that plays a major role in blood homoeostasis and reproduction in
mammals. In vertebrates, both transmembrane and soluble ACE,
containing one or two homologous active sites, have been charac-
terized. So far, several ACEs from invertebrates have been cloned,
but only in insects. They are soluble and display a single active site.
Using biochemical procedures, an ACE-like activity was detected
in our model, the leech, Theromyzon tessulatum. Annelida is the
most distant phylum in which an ACE activity has been observed.
To gain more insight into the leech enzyme, we have developed a
PCR approach to characterize its mRNA. The approx. 2 kb cDNA
has been predicted to encode a 616-amino-acid soluble enzyme
containing a single active site, named TtACE (T. tessulatum ACE).
Surprisingly, its primary sequence shows greater similarity to ver-
tebrates than to invertebrates. Stable in vitro expression of TtACE
in transfected Chinese-hamster ovary cells revealed that the leech
enzyme is a functional metalloprotease. As in mammals, this
79 kDa glycosylated enzyme functions as a dipeptidyl carboxy-
peptidase capable of hydrolysing angiotensin I to angiotensin II.
However, a weak chloride inhibitory effect and acetylated N-
acetyl-SDKP (Ac SDAcKP) hydrolysis reveal that TtACE activity
resembles that of the N-domain of mammalian ACE. In situ
hybridization shows that its cellular distribution is restricted to
epithelial midgut cells. Although the precise roles and endogenous
substrates of TtACE remain to be identified, characterization of
this ancestral peptidase will help to clarify its physiological roles
in non-insect invertebrate species.
Key words: angiotensin-converting enzyme, cloning, enzymic
activity, evolution, invertebrate, leech.
INTRODUCTION
Angiotensin-converting enzyme (dipeptidyl-peptidase A, kini-
nase II; EC 3.4.15.1, dicarboxypeptidase 1, DCP1; referred to as
ACE) is a dipeptidyl carboxypeptidase belonging to the M2-metal-
loprotease family. Within the renin–angiotensin system, this zinc-
dependent metalloprotease converts the inactive decapeptide
Ang I (angiotensin I) into the vasopressor octapeptide Ang II.
ACE also inactivates bradykinin, a vasodilator peptide, and thus
contributes to blood pressure increase in mammals (see [1,2] for
reviews). In vertebrates, two separate isoforms have been charac-
terized: somatic (sACE) and testicular (germinal) ACE (tACE)
are encoded by a single gene from two alternate promoters. This
gene arose from an ancestor gene possessing a unique active-site-
coding region [3]. sACE and tACE differ with regard to the num-
ber of their active sites: sACE presents two highly conserved glu-
zincin active sites, HEXXH, whereas tACE possesses only one,
corresponding to the C-terminal domain of sACE. sACE N- and
C-terminal active sites (referred to as N- and C-domains respect-
ively) have distinct enzymic activities on endogenous and/or syn-
thetic substrates. In addition, inhibitors of ACE can discriminate
between the two domains. For example, it has been shown that the
C-domain is responsible for the major part of Ang I hydrolysis
by sACE [4]. In contrast, N-domain ACE cleaves more efficiently
the haematoregulatory peptide N-acetyl-SDKP [5] and Ang 1–7
[6]. Both sACE and tACE present a C-terminal transmembrane
domain, and are membrane-anchored isoforms that can be solu-
bilized in the extracellular medium by a secretase [7–10]. This
post-translational cleavage has been reported as ‘shedding’. It
could influence ACE activity, since especially membrane-bound
forms of ACE are catalytically active in vivo [11,12]. An ACE
homologue, ACE2, has recently been characterized in humans
[13,14] and mice [15]. Being membrane-bound, the single active
site ACE2 functions as a monocarboxypeptidase and is insensitive
to the classical ACE inhibitor captopril [13,16]. ACE2 competes
with ACE for Ang I in humans and, furthermore, degrades Ang
II to Ang 1–7. Therefore ACE2 (through the ACE/ACE2 ratio) is
an essential regulator for functioning of the heart.
In invertebrates, ACE-related genes have only been cloned in
insects so far. Interestingly, all these genes encode soluble, single
active-site enzymes [17–19]. In the fruitfly, Drosophila melano-
gaster, six potential genes encoding ACE-like proteins have been
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identified in silico. Two zinc-binding-pattern-conserved cDNAs
have been cloned, encoding homologous enzymes and named
AnCE [20] and Race [17]. Both AnCE and Race show approx.
40% amino acid sequence identity with ACEs from vertebrates
and share similar enzymic properties [21] while acting on a broad
range of substrates. Moreover, these latter enzymes, which have
not been reported to be involved in volaemia, were demonstrated
to play a key role in development [13,22,23] and reproduction
[24–26].
To our knowledge, no ACE-like protein has been characterized
so far at the molecular level in non-insect invertebrates. In addi-
tion, no functional ACE is present in the genome of the nematode
Caenorhabditis elegans. In this worm, Brooks et al. [27] identified
genes encoding non-peptidase homologues among which ACN-1
(C. elegans ACE-like non-peptidase 1) has recently been demon-
strated to play a crucial role in development despite being cata-
lytically inactive. This raises relevant phylogenic questions about
the appearance of ACE during the course of evolution and the
situation encountered in more distant groups.
Our model, the freshwater-living leech, Theromyzon tessulatum
(Annelida; Clitellata; Hirudinida; Hirudinea; Rhynchobdellida;
Glossiphoniidae), is an aquatic-bird ectoparasite; its life cycle has
been divided into four stages according to its three blood meals.
The third and last meal induces drastic morphological as well as
physiological modifications such as a significant weight increase
and induction of sexual maturation. Based on a recent phylogene-
tic classification (see Tree Of Life Web Project at http://tolweb.org
and [28] for references), this Lophotrochozoa leech is considered
to be at least as distant from vertebrates as the Ecdysozoa C. ele-
gans. However, biochemical procedures have shown previously
that an active ACE-like enzyme is present in T. tessulatum [29,30],
suggesting that this leech contains an ancestral ACE-like protease.
In the present study, we report the molecular cloning and bio-
chemical characterization of TtACE (T. tessulatum ACE), an
ACE-like enzyme in T. tessulatum. To our knowledge, TtACE is
the first non-insect invertebrate functional ACE-like enzyme ever
cloned. To gain more insight into the evolutionary steps of ACE
and to question its putative physiological roles in the leech, en-
zymic assays were performed on recombinant TtACE expressed
in CHO-K1 cells (where CHO cell stands for Chinese-hamster
ovary cell), together with multiplex semi-quantitative RT (reverse
transcriptase)–PCR studies and in situ hybridization.
EXPERIMENTAL
Animals
Mature specimens of the leech, T. tessulatum, reared under labora-
tory conditions by the method described by Malecha [31], were
used in the present study. Leeches’ developmental stages were as-
sessed according to their three blood meals (stage 0, from birth
to the first meal; stage 1, between the first and the second meals;
stage 2, between the second and the third meals; and stage 3,
after the third and last meal). Stage 3 is subdivided into several
periods as follows: early stage 3 completes the leech’s genital
tract maturation; however, leeches naturally die after egg laying
and hatching, which terminate stage 3.
Reverse transcription
Total RNA was isolated from tissues of stage 1, 2 and 3 leeches
by the guanidium thiocyanate/phenol/chloroform method using
TRIzol® according to the manufacturer’s instructions (Gibco
BRL, Cergy-Pontoise, France). Equivalent amounts of RNA
(5 µg) were reverse-transcribed with 200 units of Superscript II
RT (Invitrogen) according to the manufacturer’s instructions,
using dT adapter (5′-CGAGTCGACATCGATCGTTTTTTTTTT-
TTTTTTT-3′) as an antisense primer for the reaction.
Molecular characterization
The full-length TtACE cDNA sequence was obtained by primer
walking on a PBM8-orientated stage 2 T. tessulatum plasmid
cDNA library (Biomethodes, Evry, France). Degenerate sense
and antisense primers (ACEinv-S1, 5′-GTSTGYCAYGCSWSY-
GCSTG-3′; ACEinv-AS1, 5′-GCYTCRTGRAASCCSGGRTT-
3′) were designed within the highly conserved regions surrounding
the active site, HEXXH, of ACE in numerous vertebrate as well
as invertebrate species, i.e. VCHASAWDFY and GANPGFHEA.
PCRs were performed on 50 ng of PBM8 cDNA library in a
Mastercycler gradient thermal cycler (Eppendorf). Cycling para-
meters were 5 min, 94 ◦C; 30 cycles: 1 min, 94 ◦C; 1 min, 42 ◦C;
1 min 30 s, 72 ◦C; and 5 min, 72 ◦C. The expected 180 bp pro-
ducts (according to various known ACE sequences) were resolved
on a 2% (w/v) agarose gel stained with ethidium bromide and sub-
cloned into the pGEM-T easy vector (Promega, Charbonnie`res,
France). They were sequenced using fluorescent dideoxytermi-
nator (ABI Prism BigDye Terminator Cycle Sequencing Ready
Reaction kit) on an ABI prism 310 sequencer (both from Applied
Biosystems) with pGEM-T easy-specific primers (F23, 5′-CCC-
AGTCACGACGTTGTAAAAGG-3′; R23, 5′-AGCGGATAAC-
AATTTCACACAGG-3′).
Characterization of this fragment allowed us to design homo-
logous primers, subsequently used in PCRs for the complete
TtACE cDNA cloning. The 5′ part of TtACE cDNA sequence was
obtained from successive PCRs upstream of the coding region
(i.e. primer walking) using antisense homologous primers. These
primers were designed from previously characterized PBM8-s1
(5′-CGCCGTTACAGATCCAAGCTCC-3′)/LACESAS1 (5′-AG-
GCCACGGAATTGAAGATCC-3′) PCR product sequences. The
3′ part of TtACE was achieved using LACESS1 (5′-TCCAAGTG-
GTGGCACAACAGG-3′) and dT adapter primers. The PCR con-
ditions were similar to those described above, except the annealing
parameters that were adapted to each pair of primers (data avai-
lable on request). Products were subcloned and sequenced as
described above.
Similar degenerate primers (ACEinv-S1 and ACEinv-AS1)
were also used to assess the presence of an ACE-like enzyme in
other annelid species (Erpobdella octoculata, Hirudo medicinalis
and Nereis diversicolor) using the procedure described above.
Nested PCRs under the same conditions were performed when
required.
Cloning of full-length TtACE cDNA and expression in cultured
mammalian cells
Construct
Full-length TtACE cDNA was amplified by PCR (94 ◦C, 3 min;
30 cycles: 94 ◦C, 1 min; 59.5 ◦C, 40 s; 72 ◦C, 2 min; and 72 ◦C,
5 min) from the PBM8 cDNA library (50 ng) by 5 units of Pfu
DNA polymerase (Promega) using specific primers (LACEFLS3,
5′-GAATTGCTCGAGTCGACCCACGCGTCCG-3′; LACE-
FLAS4, 5′-AAGTGGTAGAAAAATTATGAAATGACATAAA-
ATC-3′) based on the sequence characterized by the procedure de-
scribed in the Molecular characterization section. These primers
were designed from sequences upstream of the stop codon in po-
sition − 15, and downstream of the stop codon within the 3′-UTR
(3′-untranslated region) respectively. Products were nested with
LACEFLS4 (5′-CGCGTCCGGATGATTTTTTAAATGTTTCG-
3′) and LACEFLAS4 under the same PCR conditions, subcloned
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and sequenced as described above. Full-length TtACE cDNA was
cloned into the EcoRV site of pcDNA3.1 plasmid (Invitrogen).
The sequence of the obtained pTtACE construct was verified first
by restriction profile and then by sequencing as described above,
using pcDNA3 primers (sense, 5′-ACTACAGGGAGACCCAA-
GC-3′; antisense, 5′-AGTCGAGGCTGATCAGCG-3′) as well as
internal TtACE-specific primers.
Expression
CHO-K1 cells were cultured on FB6 plates in Dulbecco’s modi-
fied Eagle’s medium (Gibco BRL) with serum until 85–90%
confluent. Cells were stably transfected with 1 µg of pTtACE
per well using LIPOFECTAMINETM 2000 reagent (Invitrogen) ac-
cording to the manufacturer’s instructions, and were selected for
resistance to Geneticin. Individual resistant colonies producing
large amounts of TtACE were cloned by limiting dilution tech-
niques as described previously [4].
Immunological characterization of recombinant TtACE
Secreted recombinant TtACE was obtained from the culture me-
dium of transfected CHO cells grown for 2 days in serum-free
medium (ULTRA CHO). After concentration, the recombinant
enzyme was analysed by SDS/PAGE, followed by Western-blot
analysis. To characterize the TtACE enzyme, a rabbit antiserum
(TtAb1) was raised against a peptide corresponding to the se-
quence 403–417 (HEAIADIASLSVATP). The peptide and anti-
sera were provided by Neosystem (Strasbourg, France).
Enzymic assays
ACE activity was measured using different substrates. Hip-His-
Leu (HHL; 5 mM; Hip, Hippuryl) and AcSDAcKP (0.5 mM;
where Ac is N-acetyl) were used as human C- and N-domain-
specific substrates respectively [32,33]. Ang I (25 µM) was used
as both a human C- and N-domain substrate and HHL-NH2
(5 mM) as an amidated substrate.
Assays were performed at 37 ◦C with 25 µl of TtACE culture
medium for 30 or 60 min. The rate of hydrolysis of all substrates
used was resolved and quantified by reverse HPLC (Waters,
Milford, MA, U.S.A.). The specificity of the reaction was
confirmed in the presence of 1 µM of the ACE inhibitor, lisinopril.
The effect of chloride on HHL hydrolysis was determined under
standard conditions with NaCl concentrations ranging from 0 to
1000 mM. Activity of TtACE was compared with that of the N-
or C-domain of human ACE, as described previously [4].
Inhibition of Mca-ASDK-DpaOH hydrolysis by various
ACE inhibitors
Inhibition studies were performed with Mca-ASDK-DpaOH
[where Mca stands for (7-methoxycoumarin-4-yl)acetyl- and
DpaOH stands for N3(2,4-dinitrophenyl)L-2,3-diaminopropionyl-
OH] as a fluorescent ACE substrate, as described previously [34].
Assays were performed by recording fluorescence at 390 nm.
The potency of captopril and delaprilat for the inhibition
of Mca-ASDK-DpaOH hydrolysis by recombinant TtACE was
determined by establishing dose-dependent inhibition curves at
equilibrium. The compounds were preincubated with TtACE for
1 h and reactions were initiated by the addition of 12 µM of
substrate.
To compare the effects of these inhibitors, the same dose-
dependent curves were studied with recombinant C- and N-sites
of human ACE.
Inhibition of Mca-ASDK-DpaOH hydrolysis by ACE mAb
(monoclonal antibody)
mAb i2H5 (a gift from Dr S. Danilov, Department of Chemistry,
Moscow State University, Russia), an mAb raised against purified
human lung ACE, recognizes epitopes in the N-terminal domain
of ACE and inhibits the enzymic activity of the N-terminal active
site only [35]. The inhibitory potency of mAb i2H5 towards the
recombinant TtACE and C- and N-active sites of human ACE was
determined by establishing dose-dependent inhibition curves.
Northern-blot analysis
Total RNA was extracted as described above, and was poly(A)+
(polyadenylated)-enriched using oligo(dT) resin-affinity chro-
matography. Poly(A)+ RNA (10 µg) from stage 2 leeches was
subjected to Northern-blot analysis as described by Breton et al.
[36]. A [32P]dCTP-radiolabelled 280-bp cDNA probe correspond-
ing to nt 1426–1705 of TtACE cDNA sequence was generated
with the Ready-to-go labelling kit (Amersham Biosciences).
Nylon membranes were hybridized overnight at 42 ◦C and washed
[final stringency conditions were 0.5 × sodium citrate and 0.1%
(w/v) SDS; 45 ◦C for 15 min]. Autoradiograms (Kodak) were
visualized after exposure for 16 h at room temperature (20 ◦C).
Multiplex semi-quantitative PCR
Semi-quantification of TtACE expression was performed using
the multiplex relatively quantitative RT–PCR validated method
[37,38]. The constitutively expressed housekeeping gene, β-actin,
was used as an internal standard (the sequence data for T.
tessulatum is available at the GenBank® database under the acces-
sion no. CK640381). β-Actin primers (AcF, 5′-GATCTGGCA-
TCACACCTTCTACAA-3′; AcR, 5′-GTTGAAGGTCTCGA-
ACATGATCTG-3′) were kindly provided by Dr C. Lefebvre
(Laboratoire de Neuroimmunologie des Anne´lides, University
of Lille 1). cDNA from stage 1 (n = 10), stage 2 (n = 10) and
stage 3 (n = 8) leeches were obtained by the method described
above. They were used as templates in 27-cycle PCRs. Previous
experiments have allowed us to determine that 27 cycles corres-
pond to the number of reaction steps required for the maximal
exponential amplification phase of β-actin before reaching the
plateau phase (results not shown). Each tube contained the fol-
lowing mixture: 50 ng of cDNA; 2 pmol each of the primers
LACESS1 and LACESAS1, as well as AcF and AcR; 20 µM
dNTPs; 1 unit of Taq DNA polymerase; MgCl2 in an appropriate
buffer and water to a final volume of 50 µl. PCR cycling con-
ditions were 94 ◦C, 3 min; 27 cycles: 94 ◦C, 40 s; 52 ◦C, 1 min;
72 ◦C, 1 min. Negative and positive controls were performed on
water and 50 ng of pBM8 stage 2 cDNA library respectively.
Products were resolved by 2% agarose-gel electrophoresis,
stained with ethidium bromide as described above and digitally
photographed under UV light (312 nm). Absorbance was analysed
with the Claravision system v5.1 (Claravision Perfect Image
software and Claravision Gel Analyst software; Claravision,
Orsay, France). Statistical analysis was performed using unpaired
Student’s t test.
In situ hybridization
Cellular localization of TtACE mRNA synthesis was investigated
by in situ hybridization on stage 2 and stage 3 leeches. Leeches
were fixed overnight in 0.1 M phosphate buffer containing 4%
(w/v) paraformaldehyde (pH 7.4). After dehydration, animals
were embedded in paraplast and 7 µm sections were cut, mounted
on poly(L-lysine)-coated slides and stored at 4 ◦C until use. The
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Figure 1 Amino acid sequence alignment between TtACE and ACEs of various species
This alignment was obtained in silico using Clustal W software (available at http://www.ebi.ac.uk/clustalw/). HumtACE, H. sapiens C-domain ACE (GI: 113041); DrmAnCE, D. melanogaster AnCE
(GI: 26006940); ACN-1, C. elegans ACE-like non-peptidase 1 (GI: 25151555). Amino acids are numbered on the right side of the first methionine residue. Dashes represent gaps. The residues
identical between all sequences are shown in white within black boxes. The conserved amino acids with regard to TtACE are shaded grey. The M2 active site is boxed. TtACE putative signal peptide is
underlined.
labelled, approx. 1 kb, cRNA probe was obtained from the library
by PCR using the primers LACESS1 and dT adapter. The cDNA
fragment (nt 1123–1848 and a part of the 3′-UTR) was cloned
in pGEM-T easy (Promega) and sequenced as described above.
[35S]UTP-labelled antisense and sense riboprobes were generated
from linearized cDNA plasmids by in vitro transcription using
SP6/T7 RNA-labelling kit (Roche). 35S-labelled riboprobes
(100 ng or 1 × 106 c.p.m./slide) were hybridized as described pre-
viously [39]. Slides were observed under a Zeiss Axioscope
microscope. The control consisted of replacing the antisense
c© 2004 Biochemical Society
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riboprobe with a sense riboprobe. RNAse control sections were
obtained by adding a preincubation step with 10 mg/ml RNAse A
before hybridization.
RESULTS
Molecular characterization
Using a PCR approach, we cloned an approx. 2 kb cDNA frag-
ment presenting a 1848 bp ORF (open reading frame). This ORF
possesses a transcription start (position 1), is delimited by two
in-frame 5′- and 3′-stop codons (positions −15 and 1849 respec-
tively) and a putative polyadenylation signal in the 3′-UTR. This
ORF corresponds to the putative 616-amino-acid leech enzyme
(GenBank® accession no. AY560004). It contains the zinc-bind-
ing motif HEXXH (positions 376–380) and the putative third zinc
ligand, a glutamic residue located 24 amino acids downstream
of the second histidine residue of this motif (position 403).
Hydrophobicity predictions (SignalP V1.1, available at http://
www.cbs.dtu.dk/services/SignalP) suggested post-translational
cleavage of a signal peptide between residues 23 and 24
(SVLES↓ATIL). The deduced primary sequence revealed that, in
agreement with what has been found in invertebrates, the enzyme
did not seem to contain a C-terminal transmembrane domain.
Moreover, the PROSCAN bioinformatics prediction tool program
(available at http://cbs.dtu.dk/services/NetNGlyc/) emphasized
the presence of six potential N-glycosylation sites. The in silico
glycosylphosphatidylinositol-anchor-site prediction tool (big-
PI Predictor, available at http://mendel.imp.univie.ac.at/gpi/cgi-
bin/gpi_pred.cgi) [40] did not detect any pattern likely to undergo
such a modification in the TtACE primary sequence. Taken to-
gether, these results suggested that TtACE might only exist under
a soluble form. Subsequently, after the signal peptide cleavage
and assuming that all potential sites had undergone N-glycosyl-
ation, the predicted molecular mass of mature TtACE was ap-
prox. 78 kDa. Interestingly, its amino acid sequence showed
greater similarity to vertebrate than to invertebrate enzymes
[53% identity with Gallus gallus ACE (GI: 1703072), 47 and
48% identity with Homo sapiens N- and C-domains respectively
(GI: 37790804) and 39% identity with D. melanogaster
AnCE (GI: 26006940) according to the BLAST server (http://
www.ncbi.nlm.nih.gov/blast/bl2seq/bl2.html)] [41]. Its primary
sequence indicated that TtACE bore every functional residue at
conserved positions for zinc ions (His376 and His380), chloride ions
(Arg180, Tyr218, Trp478, Arg48 and Arg515) and lisinopril (His346,
Ala347, Glu377, Lys504, His506, Tyr51 and Tyr517) binding when com-
pared with human tACE [41,42] (Figure 1). Using the same ap-
proach, we cloned partial cDNA and found the existence of an
ACE-like enzyme in all of the water-living annelid species
examined, including non-parasitic (Erpobdella octoculata, Nereis
diversicolor) as well as parasitic species (Hirudo medicinalis).
The characterized sequences were all highly conserved in these
species (i.e. more than 70% homology in nucleotides) whether
parasitic or not (results not shown). It is noteworthy that, although
all other known ACE sequences of the animal kingdom present a
glutamic residue at position 6 after the last histidine of the zinc-
binding motif HEXXH (according to the MEROPS database re-
lease 6.3, available at http://merops.sanger.ac.uk), a histidine resi-
due was identified at this position in every annelid ACE sequence.
Biochemical characterization of recombinant TtACE
Expression of secreted TtACE in CHO cells
Culture medium of recombinant stable CHO cells was analysed
by SDS/PAGE followed by Western-blot analysis. Recombinant
Figure 2 Western-blot analysis of recombinant TtACE
TtACE expressed in CHO cells was analysed by SDS/PAGE, followed by Western-blot analysis
with the antiserum TtAb1. Lane a, molecular-mass standards; lane b, recombinant TtACE.
Figure 3 Hydrolysis of Ang I, AcSDAcKP, HHL and HHL-NH2 by TtACE
Profiles are as follows: (A) Ang I (peak 2), Ang II (peak 1); (B) AcSDAcKP (peak 4), AcKP (peak
3); (C) HHL (peak 6), hippuric acid (peak 5); and (D) HHL-NH2 (peak 8), hippuric acid (peak 7).
Inhibition of TtACE activity by 1 µM lisinopril is indicated (· · · · · · · · ·).
TtACE migrated with an apparent molecular mass of 79 kDa
(Figure 2).
Enzymic properties of recombinant TtACE
The enzymic activity of recombinant TtACE was studied using the
mammalian ACE substrate Ang I and two synthetic substrates,
specific to the N- and the C-domain active sites of ACE, namely
AcSDAcKP and HHL respectively. Recombinant TtACE hydro-
lysed the three substrates, as shown by HPLC analysis (Fig-
ures 3A–3C). TtACE hydrolysed HHL-NH2, a substrate with a
blocked C-terminus (Figure 3D). All these hydrolyses were fully
inhibited by 1 µM lisinopril.
Since chloride dependence of HHL hydrolysis is a good index
of the N- or C-domain property of the active sites of ACE, TtACE
c© 2004 Biochemical Society
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Figure 4 Inhibitory effects of various ACE inhibitors on the hydrolysis of HHL by recombinant TtACE
Effects of captopril (H17009) and delaprilat () on recombinant TtACE (A) and the N- (B) or C-terminal (C) functional active sites of human ACE. Results are expressed as the means for three experiments.
(D) Effects of various chloride concentrations on the hydrolysis of HHL by recombinant TtACE (H17009) and the N- and C-domains of human ACE ( and respectively). Recombinant TtACE from
culture medium was dialysed against distilled water and various chloride concentrations were added to aliquots of the dialysed medium. Activity of ACE towards HHL was determined and compared
with that of the single active-site N- and C-domains of ACE as described in [4].
activity under different chloride concentrations was assessed
(Figure 4D). TtACE maximal activity was observed at 50 mM Cl−
concentration, similar to the single N-domain of human ACE.
Effect of two ACE inhibitors on TtACE activity
Inhibition of TtACE was studied using two mammalian ACE inhi-
bitors selected for their ability to inhibit differentially either the
N- or C-domain of human ACE, captopril and delaprilat res-
pectively. TtACE was more potently inhibited by captopril (IC50 =
5.5 nM) than by delaprilat (IC50 = 20.7 nM), a result similar to that
observed with the two human ACE domains (Figures 4A–4C).
Finally, TtACE activity was inhibited by mAb i2H5 in a manner
similar to human N-domain (result not shown).
mRNA expression
Results of Northern-blot analysis showed the existence of a
major transcript of approx. 3 kb and a minor one migrating with
an apparent molecular mass of 4.2 kb (Figure 5A). Performing
multiplex semi-quantitative RT–PCR experiments using β-actin
as an internal standard, we found variable amounts of ACE mRNA
at all stages (stages 1–3) of the leech’s life cycle (Figure 5B).
TtACE mRNA was present from stage 1 and its expression level
was similar at stages 1 and 2. However, a lower mRNA expression
level was detected at stage 3, as assessed by fluorescence analysis
of agarose gels (Figure 5C).
Cellular localization
After in situ hybridization analysis of the whole body, TtACE
mRNA labelling was exclusively observed in the epithelial cells
of the midgut from stage 2 leeches (Figure 6). No labelling could
be detected in stage 3 animals or in any other tissue, e.g. the re-
productive tract.
DISCUSSION
The present study brings molecular evidence for the existence
of a functional ACE-like enzyme in non-insect invertebrates. It
describes the first cloning of cDNA and the biochemical activity
and distribution of an ACE-like enzyme in the leech, T. tessulatum,
named TtACE. To date, only biochemical data about ACE-like
activities in these species are available [29,43]. Their cDNA
structure has never been identified so far. The 1848-bp cDNA ORF
of TtACE encodes a putative 616-amino-acid protein of 79 kDa.
This protein does not possess a membrane anchor, contains a
unique M2 catalytic active site and shares a common structure
with ACE from insects. However, its amino acid sequence shows
a higher homology with ACE from vertebrates, particularly with
ACE from chicken. Since the leech, T. tessulatum, is the only
Lophotrochozoa species in which an active ACE-like enzyme has
been characterized at the molecular level, TtACE may help us to
address numerous questions that remain to be answered.
One relevant point concerns phylogenic and evolutive consider-
ations, since C. elegans does not contain any functional ACE-like
enzyme in its genome. Since C. elegans and arthropods belong to
the Ecdysozoa group and T. tessulatum to the Lophotrochozoa, the
present study brings evidence that appearance of a functional
ACE-like protein occurs before or at the formation of the Bilat-
eria (see Tree Of Life Web Project at http://tolweb.org and [28]
for references). Interestingly, a non-peptidase ACE-like protein
(ACN-1) has been identified in the C. elegans genome and has
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Figure 5 TtACE mRNA Northern-blot profile (A), multiplex semi-quan-
titative RT–PCR expression pattern during the life cycle of T. tessulatum
(B) and the associated semi-quantification (C)
(A) kb, molecular-mass standards. (B) TtACE, 281 bp amplicon corresponding to TtACE;
β-actin, 165 bp amplicon corresponding to β-actin. Lane –, negative control achieved using
water instead of cDNA; lane L, positive control performed on a 50 ng pBM8 cDNA library;
lane MM, 100 bp molecular-mass standards; lanes 1, 2 and 3, triplicate reactions on cDNA
of stage 1, 2 and 3 animals respectively. The gel shown is representative of 28 experiments.
(C) Semi-quantitative analysis of TtACE expression reported for β-actin expression. Agarose
gels were digitally photographed with Claravision Perfect Image software v5.1 and analysed using
the Claravision Gel Analyst software v5.1. The stage of the leech’s life is indicated (stages 1–
3) below the corresponding line. The TtACE/β-actin signal ratio is expressed in arbitrary units
and values are the means +− S.E.M. for n = 10 (stage 1), n = 10 (stage 2) and n = 8 (stage 3)
independent experiments. Statistical analysis was performed using unpaired Student’s t test.
**P < 0.01; ***P < 0.001, compared with stage 1 TtACE/β-actin ratio.
very recently been demonstrated to play a key role in development
[27]. However, the reason why the C. elegans enzyme lost its
protease activity remains to be elucidated. In any case, our results
raise very interesting questions about the putative primitive and
original functions of ACE-like enzymes in the animal kingdom. In
view of the higher sequence homology between the isoforms from
leeches and vertebrates than those identified in other non-annelid
invertebrates, we speculated that this could be specific to the leech,
T. tessulatum, an aquatic-bird parasite. We thus decided to look
for the presence of a 180-bp ACE cDNA fragment surrounding the
active site in non-parasitic annelid species. The existence of such
a cDNA fragment, which shows a great sequence identity with
TtACE even in non-parasitic annelid species, indicates that an
active ACE-like protease is present in all the annelids studied,
and its presence does not seem to be dependent on parasitic
biology. Altogether, our results indicated that annelids contain
a presumably active ACE-like protein that includes an active site,
possessing a higher sequence identity with ACE from vertebrates
than with insects’ enzymes. Interestingly enough, all the annelid
ACE-like enzymes characterized possessed a specific histidine
residue located six amino acids downstream of the zinc-binding
motif. This amino acid seems to be unique to annelids since it is
replaced by a glutamic residue in all the biologically active ACE-
like enzymes cloned so far. However, this conserved amino acid
residue has not been demonstrated to play an important catalytic
role in the active site of ACE as assessed by NMR and X-ray
structural studies in human and Drosophila [42,44].
Biochemical studies of stably transfected CHO-K1 cells expres-
sing TtACE showed that the cloned leech cDNA encoded a func-
tional enzyme with a molecular mass of 79 kDa, as expected.
Hydrolysis assays on various substrates showed that TtACE was
capable of hydrolysing several mammalian ACE substrates, in-
cluding a C-amidated substrate. In this respect, TtACE, similar to
mammalian ACE, displayed an endopeptidase activity. It is inter-
esting to note that the TtACE active-site characteristics were simi-
lar to the N-domain characteristics of ACE, such as (i) low chloride
dependence on HHL hydrolysis, (ii) preferential inhibition by
N-domain-type ACE inhibitor and (iii) preferential inhibition
by an mAb specific to the N-domain. This shows that the N-do-
main characteristics of ACE are already present in a distant
organism such as the leech.
To gain more insight into the physiological functions of TtACE,
we compared its mRNA expression levels at different stages of
the leech’s life cycle. TtACE mRNA was detected at all the stages
examined, but did not show any significant quantitative variation
between stages 1 and 2 (i.e. after the first and the second blood
meals respectively). In contrast, a remarkable decrease in the ex-
pression level of the TtACE gene occurred at stage 3 after the last
blood meal. During the first two stages, the morphology of leeches
was not markedly affected. Important diuretic mechanisms took
place, leading to concentration of the host’s blood cells. In con-
trast, the last blood meal induced drastic morphological and
physiological changes such as a significant weight increase and in-
duction of sexual maturation. Thus the expression level of TtACE
was the lowest when digestion and ovogenesis were completed,
Figure 6 Microphotographs of stage 2 T. tessulatum sections after in situ hybridization
Radiolabelling is visible as black dots. (a) Antisense riboprobe, magnification × 20; (b) antisense riboprobe, magnification × 40; (c) sense riboprobe, magnification × 20; m.e., midgut epithelium;
l., midgut lumen.
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suggesting a potential role of the ACE from leech in these
functions.
Surprisingly, TtACE mRNA expression was not detected in the
reproductive system, but seemed to be restricted to midgut epi-
thelial cells. Although ACE mRNA has already been shown to
be expressed in the locust and dipteran midgut, proteases from
insects, in contrast with TtACE, exhibit a wide tissue distribution.
The physiological role and the endogenous substrates of ACE
from invertebrates in the midgut remain to be elucidated, although
the high levels of ACE activity in midgut tissues of Diptera have
led to speculations about a digestive role for ACE [19], which is
consistent with our findings. As far as we know, the ACE from
invertebrates is clearly known to control only developmental and
reproductive functions [17–26]. For example, the AnCE gene,
whose genetic invalidation leads to a lethal phenotype [17], is
expressed in the spermatocytes and spermatids of Drosophila
[24]. Interestingly, in the mosquito Anopheles stephensi, an ACE
is induced by a blood meal, but accumulates secondarily in the
developing ovary [26], suggesting that the reproductive function
of the enzyme is under a dietary influence. Recently, using the
grey fleshfly Neobellieria bullata as a model, it has been shown
that ovarian ACE could be involved in the proteolysis of yolk pro-
teins, suggesting that it may be a regulator of vitellogenic and
developmental processes [45,46]. Our results did not support the
role of TtACE in the latter processes, but indicated that the solu-
ble enzyme could be secreted within the digestive tract and acts
as a final degrading enzyme of the proteic nutrients. However, we
cannot rule out that a minor mRNA expression of TtACE might
have occurred outside the midgut tissues, but was not detected by
in situ hybridization. Alternatively, as in Drosophila, T. tessulatum
may express different ACE genes that could present distinct cel-
lular distributions. Furthermore, Northern-blot analysis of TtACE
displayed two bands, suggesting either alternative splicing of
TtACE mRNA or expression of a close ACE-related gene. Never-
theless, further experiments will be needed to clarify this issue.
Comprehension of the physiological roles of TtACE will re-
quire the molecular characterization of its endogenous substrates
and/or its potential inhibitors. Although the amount of biochemi-
cal and molecular data on ACE-like enzymes from invertebrates is
increasing rapidly, little is known concerning their in vivo targets.
Understanding these functions in invertebrates could provide new,
interesting information on the roles of these ancestral peptidases.
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